Insite: CMA submission regarding Insite supervised injection site and program.
- Date
- 2011-02-17
- Topics
- Health care and patient safety
- Pharmaceuticals, prescribing, cannabis, drugs
Carter: CMA submission regarding euthanasia and assisted death
- Last Reviewed
- 2011-03-05
- Date
- 2014-08-27
- Topics
- Ethics and medical professionalism
- Population health, health equity, public health
Mental Health, Mental Illness & Addiction : CMA Submission to the Standing Committee on Social affairs, Science and Technology
- Last Reviewed
- 2012-03-03
- Date
- 2005-04-20
- Topics
- Population health, health equity, public health
- Pharmaceuticals, prescribing, cannabis, drugs
CMA's Submission to the House of Commons Standing Committee on Health: Drug Shortages
- Date
- 2012-03-29
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
CMA Presentation to the Senate Standing Committee on Social Affairs, Science and Technology - Prescription Drugs: Clinical Trials and Approval
- Date
- 2012-05-09
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
CMA's Submission to the Senate Committee on Social Affairs, Science and Technology - Prescription Pharmaceuticals in Canada: The Post-Approval Monitoring of Prescription Pharmaceuticals
- Date
- 2012-10-24
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
CMA Response: Health Canada's Medical Marijuana Regulatory Proposal
- Date
- 2013-02-28
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
The Need for a National Strategy to Address Abuse and Misuse of Prescription Drugs in Canada: Canadian Medical Association Submission to the House of Commons Standing Committee on Health
- Date
- 2013-11-27
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
Review of Controlled Drugs and Substances Act: Canadian Medical Association submission to Health Canada in response to the consultation on the Controlled Drugs and Substances Act and its regulations
- Date
- 2014-03-17
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
CMA's Submission to the Senate Committee on Social Affairs, Science and Technology as part of its study on prescription pharmaceuticals: Federal levers to address unintended consequences of prescription pharmaceuticals and support public health, quality care, and patient safety
- Date
- 2014-03-26
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
Canadian Medical Association submission to the Standing Senate Committee on Banking, Trade and Commerce: Higher rate now: Why excise tax on tobacco is long overdue for an increase
- Date
- 2014-05-15
- Topics
- Health care and patient safety
- Pharmaceuticals, prescribing, cannabis, drugs
The Health risks and harms associated with the use of marijuana
- Date
- 2014-05-27
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
Amendments to PIPEDA, Bill S-4
- Date
- 2014-06-09
- Topics
- Health information and e-health
- Ethics and medical professionalism
Bill C-17 An Act to amend the Food and Drugs Act
- Date
- 2014-06-11
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
Proposed amendments to the marihuana for medical purposes regulations
- Date
- 2014-07-11
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
Tamper Resistance under the Controlled Drugs and Substances Act
- Date
- 2014-08-26
- Topics
- Health care and patient safety
- Pharmaceuticals, prescribing, cannabis, drugs
Bill C-2 An Act to amend the Controlled Drugs and Substances Act (Respect for Communities Act)
- Date
- 2014-10-28
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
Bill C-2 An Act to amend the Controlled Drugs and Substances Act (Respect for Communities Act)
- Date
- 2015-05-14
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
Complementary and alternative medicine (update 2015)
- Date
- 2015-05-30
- Topics
- Health care and patient safety
- Pharmaceuticals, prescribing, cannabis, drugs
Harms associated with opioids and other psychoactive prescription drugs
- Date
- 2015-05-30
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs